Danaher DHR
NYSE DHR
$212.54 +4.18 (+2.01%)
As of: Sep 17, 2026 · 3:59 PM EDT

Danaher (DHR) Revenue Growth (3y) (2012 - 2026)

Analysis

Danaher (DHR) Revenue Growth (3y) (2012 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue Growth (3y) (Qtr)
1 Thermo Fisher Scientific 241.68 Bn 237.61 Bn 8.34 Bn 3.92%
2 Danaher 147.34 Bn 142.99 Bn 3.61 Bn 1.95%
3 Agilent Technologies 43.34 Bn 41.59 Bn 1.04 Bn 3.95%
4 Illumina 34.58 Bn 33.41 Bn 770.00 Mn -0.48%
5 Revvity 16.31 Bn 15.29 Bn 416.87 Mn 0.96%
6 Bio-Techne 11.28 Bn 11.01 Bn 211.39 Mn 2.15%
7 Bio-Rad Laboratories 10.16 Bn 8.54 Bn 345.80 Mn -1.50%
8 Repligen 9.77 Bn 8.75 Bn 110.04 Mn 8.65%
9 10x Genomics 9.45 Bn 8.90 Bn 112.50 Mn 0.95%
10 Bruker 9.26 Bn 9.04 Bn 416.00 Mn 7.13%
Historic Data

Historic Data

Download Data
DateValue
Jun 26, 2026 1.95%
Mar 27, 2026 0.01%
Dec 31, 2025 -1.40%
Sep 26, 2025 -2.12%
Jun 27, 2025 -3.12%
Mar 28, 2025 -4.18%
Dec 31, 2024 23.19%
Sep 27, 2024 -7.09%
Jun 28, 2024 -7.34%
Mar 29, 2024 -5.45%
Dec 31, 2023 -1.78%
Sep 29, 2023 -1.50%
Jun 30, 2023 3.73%
Mar 31, 2023 11.06%
Dec 31, 2022 13.58%
Sep 30, 2022 13.82%
Jul 1, 2022 13.67%
Apr 1, 2022 15.64%
Dec 31, 2021 -8.76%
Oct 1, 2021 20.09%